top of page
​IMANs are the ultimate cancer immuno-surveillance cell for preventing tumour escape. IMANs have been designed to last much longer than normal neutrophils and have excellent threat pattern recognition, which enables them to find and destroy tumours directly and by recruiting the rest of the immune system.
Our forthcoming clinical trial aims to show that by replacing patients dysfunctional innate immune cells with IMANs we can reconstitute their innate immune competence and enable them to overcome their cancer.
bottom of page